glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase

forms O-glycan core I; forms galactosyl beta 1,3-N-acetylgalactosaminide mucin

Also Known As:

C1beta3GalT protein, human; GalNAc-1-O-Ser or Thr 1-3 galactosyltransferase; UDP-Gal-N-acetylgalactosaminide mucin-beta 1,3-galactosyltransferase; UDP-galactose-N-acetylgalactosamine-alpha-R beta3-galactosyltransferase; UDP-galactose-alpha-N-acetylgalactosaminide beta 3 galactosyltransferase; UDPGal-NACGM-galactosyltransferase; core 1 beta3-galactosyltransferase; core I beta3-galactosyltransferase; glycoprotein-GalNAc-galactosyltransferase; gp GalNac gal transferase

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Transferases: 6589
    - Glycosyltransferases: 784
      - Hexosyltransferases
        Galactosyltransferases: 243
        glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase: 1

Experts

1.	Huang, Min-Chuan: 1 article (01/2021)
2.	Lin, Mei-Chun: 1 article (01/2021)
3.	Lou, Pei-Jen: 1 article (01/2021)

Related Diseases

1.	Neoplasm Metastasis (Metastasis) 01/01/2021 - "The objective of this study is to determine the value of the anti- glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (C1GALT1) autoantibody as a biomarker for distant metastasis and good response to immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC). "
2.	Squamous Cell Carcinoma of Head and Neck 01/01/2021 - "The objective of this study is to determine the value of the anti- glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (C1GALT1) autoantibody as a biomarker for distant metastasis and good response to immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC). "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	Autoantibodies
3.	Immune Checkpoint Inhibitors